5 Results for "

ERD 1233

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "ERD 1233" in MCE Product Catalog:

Cat. No.: HY-169367
Research Areas:  

Cancer

ERD-1233 is an orally active ERα PROTAC degrader with a DC50 of 0.9 nM. ERD-1233 exhibits plasma stability and microsomal stability across multiple species, and shows no significant inhibitory effect on major cytochrome P450 subtypes and hERG channels. ERD-1233 inhibits tumor growth and degrades ERα protein levels in xenograft tumor models, with favorable biosafety. ERD-1233 can be used in breast cancer-related research .
loading...
    loading...
Cat. No.: HY-201580
CAS No.: 2229713-97-5
ER ligand-8 is an ER (Estrogen Receptor/ERR) ligand that can be used to synthesize the PROTAC molecule ERD-1233 (HY-169367) .
loading...
    loading...
Cat. No.: HY-172067
CAS No.: 3026011-20-8
ER ligand-9 is a conjugate of an estrogen receptor (Estrogen Receptor/ERR) and a linker, which can be used to synthesize PROTAC ERD-1233 (HY-169367) .
loading...
    loading...
Cat. No.: HY-W889109
CAS No.: 3026011-77-5
Target:  

PROTAC Linkers

Research Areas:  

Cancer

3-(Dimethoxymethyl)-1-oxa-8-azaspiro[4.5]decane is a PROTAC linker that can be used to synthesize ERD-1233 (HY-169367) .
loading...
    loading...
Cat. No.: HY-W1009348
CAS No.: 3026009-09-3
Target:  

Ligands for E3 Ligase

Research Areas:  

Cancer

RR-11055 (Compound 8) is a ligand for E3 ligase, that exhibits an affinity with cereblon with Ki of 0.38 μM. RR-11055 can be used for synthesis of PROTAC Degrader ERD-1233 (HY-169367) .
loading...
    loading...